Health Education Approach to Lung Screening
- Conditions
- Lung Cancer
- Registration Number
- NCT06070870
- Lead Sponsor
- Virginia Commonwealth University
- Brief Summary
Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)
- Detailed Description
This is a single-arm study of a patient navigation intervention to increase access to lung cancer screening (LCS).
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 225
- Meets current USPSTF guidelines for lung cancer screening (LCS)
- 20 pack-year smoking history Note: A pack-year is a way of calculating how much a person has smoked in their lifetime.
One pack-year is the equivalent of smoking an average of 20 cigarettes-1 pack-per day for a year.
- Currently smokes or has quit smoking within the past 15 years
- Identifies as Black or African-American Note: Both Hispanic/Latino and Non-Hispanic/Latino patients are eligible as long as they also identify as Black or African-American (eg, Afro-Latino).
- Willing to complete all navigation-related study activities
- Able to understand and the willingness to sign a written informed consent document
A patient who meets any of the following exclusion criteria is ineligible to participate in the study:
- Known history of cancer (except squamous cell skin cancer), or coughing up blood in the past 5 years, as reported by the individual
- Has undergone a previous lung cancer screening
- Inability to speak English
- Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Number of study patients who complete lung cancer screening (LCS) through the patient navigation process 2 weeks to 4 months following day 1, varies by participant Evaluate the impact of the patient navigation program on the number of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT).
- Secondary Outcome Measures
Name Time Method Assess the impact of the patient navigation program on patient health-related quality of life after navigation intervention. 2 weeks to 4 months following day 1, varies by participant Utilizing Patient-Reported Outcome Measurement Information System (PROMIS) v1.2 Global Health Scale (10 items) scores before and after navigation intervention. Patient-Reported Outcome Measurement Information System (PROMIS) v1.2 Global Health Scale (10 items), measures assess physical, mental, and social health, where 5=Never, 4=Rarely, 3=Sometimes, 2=Often, and 1=Always. Higher scores indicate better health.
Assess the feasibility and acceptability of the patient navigation program 2 weeks to 4 months following day 1, varies by participant Determine the number of participants that are satisfied with the navigation program by utilizing Was It Worth It instrument; that consists of 8 items that are are answered "yes", "no" or "uncertain" after the navigation program.
Assess the impact of the patient navigation program on patient health-related quality of life at baseline. Day 1 Utilizing Patient-Reported Outcome Measurement Information System (PROMIS) v1.2 Global Health Scale (10 items) scores before and after navigation intervention. Patient-Reported Outcome Measurement Information System (PROMIS) v1.2 Global Health Scale (10 items), measures assess physical, mental, and social health where 5=Never, 4=Rarely, 3=Sometimes, 2=Often, and 1=Always. Higher scores indicate better health.
Assess the impact of the patient navigation program on patient financial distress 2 weeks to 4 months following day 1, varies by participant Determine the number of participants that have lessening financial distress after the navigation program utilizing Financial Distress measure scores at baseline. Study-specific financial distress measure (8 items) each item will be individually coded 1-5, with 1=completely disagree to 5=completely agree and 98 for Don't know and 99 for Not applicable.
Trial Locations
- Locations (3)
University of North Carolina-Chapel Hill
🇺🇸Carrboro, North Carolina, United States
Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States
Virginia Commonwealth University
🇺🇸Richmond, Virginia, United States
University of North Carolina-Chapel Hill🇺🇸Carrboro, North Carolina, United StatesChristopher Lyu, MPAContact919-966-2865Christopher_Lyu@med.unc.eduAlison Brenner, MDPrincipal Investigator